November 4, 2019 — Abbott is recalling its CentriMag Acute Circulatory Support System due to a calibration system error resulting from electromagnetic interference that may cause the pump to slow...
Ventricular Assist Devices (VAD)
This channel includes news and new technology innovations for ventricular assist devices (VAD). VADs are a type of mechanical hemodynamic support device that helps increase blood flow in people who have ventricles that are not work properly due to heart failure, cardiogenic shock, cardiomyopathy or myocardial infarction. Most often these devices support the left ventricle, so they are often referred to as left ventricular assist devices (LVAD). VADS come in two types, surgically implanted, usually as a bridge to heart transplant, and percutanenous catheter-based pumps used for temporary hemodynamic support. Examples of temporary percutaneous pumps include the Impella and TandemHeart devices.
-
-
October 28, 2019 — Nearly two years of real-world outcomes data on Abiomed’s Impella RP heart pump shows that when physicians followed the U.S.
-
-
William O’Neill, M.D., medical director of the Center for Structural Heart Disease at Henry Ford Hospital, Detroit, explains data on first 250 patients in the National Cardiogenic Shock Initiative...
News | Hemodynamic Support Devices | November 04, 2019
November 4, 2019 — Abbott is recalling its CentriMag Acute Circulatory Support System due to a calibration system...
The new Impella clinical data is detailed in this chart was presented at an October 2019 meeting in Detroit for the management of patients in cardiogenic shock, led by the National Cardiogenic Shock Initiative (NCSI) Study principal investigators.
News | Hemodynamic Support Devices | October 28, 2019
October 28, 2019 — Nearly two years of real-world outcomes data on Abiomed’s Impella RP heart pump shows that when...
Videos | Cardiogenic Shock | October 08, 2019
Technology | Ventricular Assist Devices (VAD) | September 27, 2019
September 27, 2019 — Abiomed’s newest heart pump, the Impella 5.5 with SmartAssist, has received U.S. Food and Drug...
News | Ventricular Assist Devices (VAD) | September 12, 2019
September 12, 2019 — CorWave announced successful completion of its first 60-day preclinical study to evaluate its...
Paul Tang, M.D., Ph.D., a cardiac surgeon at Michigan Medicine’s Frankel Cardiovascular Center in the OR. Image courtesy of Michigan Medicine.
News | Ventricular Assist Devices (VAD) | August 20, 2019
August 20, 2019 — Left...
Technology | Heart Failure | July 30, 2019
July 30, 2019 – Procyrion Inc. secured Breakthrough Device designation by the U.S. Food and Drug Administration (FDA...
News | Ventricular Assist Devices (VAD) | June 12, 2019
June 12, 2019 — In a letter sent to healthcare providers, the U.S. Food and Drug Administration (FDA) validates that...
News | Ventricular Assist Devices (VAD) | May 22, 2019
May 22, 2019 — Abiomed announced that the Impella CP with SmartAssist will be commercially available beginning at...
Technology | Ventricular Assist Devices (VAD) | May 14, 2019
May 14, 2019 — The U.S. Food and Drug Administration (FDA) has approved the expansion of Abiomed’s Impella 5.0 and...
News | Ventricular Assist Devices (VAD) | May 02, 2019
May 2, 2019 — Abiomed announced that, on April 26, the U.S. Food and Drug Administration (FDA) approved initiation...
The Abiomed Impella percutaneous heart pump during a procedure at Henry Ford Hospital.
Podcast | Hemodynamic Support Devices | May 02, 2019
This podcast is a discussion with ...
The Aortic intra-aortic axial flow pump is designed to unload the heart and increase renal perfusion in heart failure patients experiencing cardiorenal syndrome.
Feature | Heart Failure | April 29, 2019 | Will Clifton, M.D.
The heart and kidneys are inextricably linked through a diverse web of hemodynamic, neural and hormonal mechanisms....
